Alimera Sciences Shares outstanding
What is the Shares outstanding of Alimera Sciences?
The Shares outstanding of Alimera Sciences Inc. is 54.384M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with shares outstanding similar to Alimera Sciences
- Lindblad Expeditions Inc has Shares outstanding of 54.319M
- BelaraRox Ltd has Shares outstanding of 54.330M
- NP3 Fastigheter AB (publ) has Shares outstanding of 54.339M
- Blackline Safety has Shares outstanding of 54.349M
- IPL Plastics has Shares outstanding of 54.382M
- Sol Cuisine Ltd has Shares outstanding of 54.382M
- Alimera Sciences has Shares outstanding of 54.384M
- 827013 has Shares outstanding of 54.385M
- Veritex Inc has Shares outstanding of 54.386M
- Smith & Wesson Brands has Shares outstanding of 54.389M
- Kudelski SA has Shares outstanding of 54.390M
- Galera Therapeutics Inc has Shares outstanding of 54.392M
- PIMCO Corporate & Income Strategy Fund has Shares outstanding of 54.406M